Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

CYP2C19 and Phase 1 Detoxification: What Your Genotype Means

Phase 1 detoxification is the body's first step in breaking down toxins, drugs, and environmental chemicals, mainly in the liver. The CYP2C19 gene makes an enzyme that helps metabolize many substances including certain pesticides, compounds from plastics, flavor enhancers, fragrances, and cannabinoids found in CBD and THC products. Variations in CYP2C19 can change how well this enzyme works and influence how efficiently your body begins the detox process.

How to Read This Report

This article explains what different genotypes for the rs4244285 variant mean for CYP2C19 activity, and provides practical, approachable strategies to support detoxification. PlexusDx does not provide medical advice. Use this information to inform discussions with your healthcare provider before making changes to medications, supplements, or medical care.

Genetic Interpretations

Two effect alleles (AA) — Poor metabolizer

If your genotype is AA at rs4244285, you carry two copies of the effect allele. This result indicates markedly reduced CYP2C19 enzyme activity. As a poor metabolizer your liver’s initial ability to break down many substances is limited. Substances affected include cannabinoids (CBD and THC), organophosphate pesticide residues, BPA from plastics, MSG, and synthetic fragrance compounds.

Potential implications

  • Slower clearance of the substances listed above
  • Longer internal exposure to hormone active or irritating compounds
  • Greater sensitivity to drugs that depend on CYP2C19 for breakdown

Practical steps

  • Avoid or limit exposure to known sources of these chemicals where possible
  • Talk with your healthcare provider about medication dosing and interactions
  • Prioritize liver support and gentle elimination strategies described below
One effect allele (AG) — Intermediate metabolizer

If your genotype is AG at rs4244285, you carry one copy of the effect allele. This is associated with moderately reduced CYP2C19 activity. Your liver still performs Phase 1 detoxification, but certain substances may be cleared more slowly than in people with typical activity.

Potential implications

  • Somewhat slower metabolism of cannabinoids, pesticide residues, BPA, MSG, and synthetic fragrances
  • Potential for prolonged exposure depending on dose and frequency of contact

Practical steps

  • Reduce avoidable exposures and practice careful product selection
  • Support nutrient status for detox enzymes with diet and targeted supplements if appropriate
  • Discuss medication metabolism with your clinician
No effect alleles (GG) — Typical metabolizer

If your genotype is GG at rs4244285, you carry two copies of the non-effect allele. This suggests typical CYP2C19 activity and normal Phase 1 detox capacity for the substrates influenced by this enzyme. Your body is likely able to initiate breakdown of many common environmental chemicals and certain drugs efficiently.

Practical steps

  • Continue general detox-supportive habits to maintain liver health
  • Remain mindful of cumulative exposures from diet, personal care products, and the environment

Dietary Recommendations to Support Phase 1 and Overall Detox

  • Eat a variety of colorful fruits and vegetables daily, focusing on cruciferous vegetables such as broccoli, Brussels sprouts, cauliflower, and kale to support liver enzyme pathways.
  • Include fiber rich foods like whole grains, legumes, apples, and flaxseed to help bind and remove metabolites through the digestive tract.
  • Ensure adequate intake of B vitamins, magnesium, and iron as these nutrients support many metabolic pathways. Aim to get these primarily from food: leafy greens, legumes, nuts, seeds, lean meats, and fortified grains where needed.
  • Choose organic produce when possible to reduce pesticide load and avoid heating or storing foods in plastics, especially when hot, to minimize BPA and plasticizer exposure.
  • Limit processed foods high in MSG and artificial additives; prefer whole, minimally processed foods.
  • Stay well hydrated. Water supports kidney filtration and helps the body eliminate water soluble metabolites produced by Phase 1.

Supplement Considerations

Discuss supplements with your healthcare provider before starting them. Suggested supplements that can support general detox pathways include:

  • Methylated B complex to support Phase 2 conjugation and overall methylation capacity
  • Magnesium to support enzyme function and energy metabolism
  • Milk thistle (silymarin) for liver cell support
  • NAC or glutathione precursors to support antioxidant defenses and conjugation steps
  • Omega 3 fatty acids to reduce systemic inflammation

Lifestyle and Environmental Strategies

  • Minimize exposure to products with synthetic fragrances. Use fragrance free or naturally scented products that list ingredients clearly.
  • Reduce use of plastics for food storage and heating. Use glass, stainless steel, or ceramic alternatives.
  • Practice smoking cessation and avoid secondhand smoke which can increase toxic burden.
  • Moderate alcohol intake. Alcohol increases liver workload and can interfere with detox pathways.
  • Exercise regularly. Physical activity supports circulation, lymph flow, and metabolic health which aids elimination.
  • Prioritize sleep and stress management. Sleep is essential for metabolic recovery and brain detox processes. Use relaxation techniques such as breathing exercises, mindfulness, or gentle movement.

When to Talk with Your Healthcare Provider

  • If you take medications that are metabolized by CYP2C19. Your genotype may affect dosing and side effect risk.
  • If you have persistent symptoms you think relate to toxin exposure or liver function.
  • Before starting any new supplement, especially those that influence liver enzymes.
  • If you work or live in environments with higher chemical exposures and need individualized monitoring.

Additional Tests and Monitoring

Consider discussing these tests with your clinician to track metabolic and liver health:

  • Standard liver panel (ALT, AST, alkaline phosphatase, bilirubin)
  • Complete blood count and iron studies if indicated
  • Nutrient panels for B vitamins, magnesium, and vitamin D where relevant
  • Targeted toxicant testing if there is known high exposure

Final Notes and Disclaimer

This report is educational and intended to help you understand how the CYP2C19 rs4244285 variant may influence the first step in detoxification. PlexusDx does not provide medical advice. Genetics is only one piece of the picture. Environmental exposures, lifestyle, diet, medications, and overall health also shape how your body handles toxins. Always consult your healthcare provider for personalized medical guidance, medication management, and before making significant changes to diet, supplements, or treatment plans.

If this genetic variant is present in your PlexusDx results, the following tests and reports are commonly used to explore it further:

🧬 Genetic Tests:

🧪 Blood Tests:

📄 Genetic Report:

Frequently Asked Questions About PHASE 1 DETOX and CYP2C19 rs4244285

What does the CYP2C19 rs4244285 genotype mean for my Phase 1 detoxification?

CYP2C19 helps drive Phase 1 detoxification—the body’s first step in breaking down many toxins, drugs, and environmental chemicals in the liver. Your rs4244285 genotype can indicate whether CYP2C19 activity is poor, intermediate, or typical, which may affect how quickly your body begins clearing substances such as cannabinoids (CBD/THC), organophosphate pesticide residues, BPA from plastics, MSG, and synthetic fragrances.

How do AA, AG, and GG genotypes at rs4244285 differ in detox-related exposure risk?

If you have AA (two effect alleles), CYP2C19 activity is markedly reduced, which can mean slower clearance and longer internal exposure to affected substances, and potentially higher sensitivity to certain CYP2C19-dependent medications. If you have AG (one effect allele), enzyme activity is moderately reduced, which may lead to somewhat slower metabolism and prolonged exposure depending on dose and contact frequency. If you have GG (no effect alleles), CYP2C19 activity is typical, suggesting normal Phase 1 detox capacity for influenced substrates.

What lifestyle and dietary steps can support detoxification based on rs4244285?

You can support Phase 1 detoxification by eating a variety of colorful fruits and vegetables (especially cruciferous options like broccoli and kale), increasing fiber intake (whole grains, legumes, apples, flaxseed) to help bind and remove metabolites, and ensuring adequate B vitamins, magnesium, and iron from food sources. You can also reduce exposure drivers by choosing organic produce when possible, avoiding heating/storing food in plastics to limit BPA/plasticizer intake, limiting processed foods high in MSG/artificial additives, staying well hydrated, and minimizing synthetic fragrances. If you take medications metabolized by CYP2C19 or plan to start supplements, discuss timing and dosing with your healthcare provider first.

What tests can help me learn more about PHASE 1 DETOX and CYP2C19 rs4244285?

The Functional Health Genetic Test delivers over 750 personalized genetic insights across 10 in-depth genetic reports to support whole-body, systems-level health understanding. The Detoxification Genetic Report translates your results into personalized, actionable guidance. Your healthcare provider can also recommend targeted blood tests based on your specific pathway results and health history to complement your genetic insights with current biomarker data.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.